Sepsis :: Biosite Reports on Presentation of Preliminary Data From Sepsis Program
Biosite Incorporated (Nasdaq:BSTE) today announced preliminary results of a sample collection study aimed at identifying a biomarker panel that could potentially aid in the assessment for risk of sepsis progression.